Breast MRI

Magnetic resonance imaging of the breast (breast MRI), commonly used for dense breasts, is a highly accurate imaging modality for detecting early breast cancer and other abnormalities without using excess radiation. It’s often used alongside digital mammograms and digital breast tomosynthesis to offer detailed visualization of breast lesion margins. 

RSS icon

Radiology: False-positives drop w/ routine breast MRI screening

Women at high risk for breast cancer undergoing their first MRI screening have higher false-positive rates and require significantly more follow-up, showing that MRIs notoriously low specificity improves as women accumulate prior MR screening histories, a study published Feb. 1 in Radiology discovered.

RSNA: Penrad acquires Clarios Compass breast MRI software

PenRad Technologies (Booth 4600) has purchased Clario Medical Imaging's Compass breast MRI visualization and analysis software, which PenRad will launch at the annual meeting of the Radiological Society of North America (RSNA), Nov. 28 to Dec. 3, in Chicago.

Clinical Breast MRI

Clinical Breast MRI Sunday, Nov. 28, 2:00 PM - 3:30 PM

JACR: Community hospitals perform breast MRI well

A majority of community hospitals comply with two common sets of guidelines for high-quality breast MRI acquisition, despite the absence of uniform standards for breast MRI in the U.S., according to a survey of community hospitals published in the November edition of the Journal of the American College of Radiology (JACR).

AJR: Breast MRI screening beneficial for some with previous cancer

Breast MRI screening of women with only a personal, not familial, history of breast cancer was clinically valuable in finding malignancies for 12 percent of all cases, with a reasonable biopsy rate of 39 percent, found a study published in the August issue of the American Journal of Roentgenology.

Breast MRI: Looking Beyond High-risk Screening

Three years ago, the American Cancer Society (ACS) updated breast cancer screening guidelines for high-risk and dense-breasted, pre-menopausal women, recommending that this subset of patients undergo breast MRI in addition to annual screening mammograms.

Molecular-based Breast Imaging: Catching Up to Breast MRI

Although breast MRI is an increasingly common complement to mammography because of its sensitivity in detecting suspicious lesions missed by mammography, two molecular imaging techniquespositron emission mammography (PEM) and breast specific gamma imaging (BSGI)are moving up the ranks due to greater physiological detail and spatial resolution both techniques offer.

iCAD nets 510(k) for interventional breast MRI app

The FDA has granted 510(k) clearance to iCAD for PrecisionPoint, its interventional planning solution for breast MRI that will be offered as an integrated module within the company's CADvue breast MRI image review software.

Displaying 89 - 96 of 129

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.